Last update 19 Jun 2024
HRS-5965
Last update 19 Jun 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms HRS 5965, HRS5965 |
Target |
Mechanism CFB modulators(Complement factor B modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Related
8
Clinical Trials associated with HRS-5965An Open Label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
评价HRS-5965片治疗阵发性睡眠性血红蛋白尿患者的长期安全性和有效性的多中心、开放研究
[Translation] A multicenter, open-label study to evaluate the long-term safety and efficacy of HRS-5965 tablets in the treatment of patients with paroxysmal nocturnal hemoglobinuria
A Trial to Evaluate the Efficacy and Safety of HRS-5965 Tablets in Primary IgA Nephropathy
100 Clinical Results associated with HRS-5965
Login to view more data
100 Translational Medicine associated with HRS-5965
Login to view more data
100 Patents (Medical) associated with HRS-5965
Login to view more data
100 Deals associated with HRS-5965
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glomerulonephritis, IGA | Phase 2 | CN | 24 Nov 2023 | |
| Hemoglobinuria, Paroxysmal | Phase 2 | CN | 07 Oct 2023 | |
| C3 glomerulopathy | Phase 1 | CN | 08 Oct 2022 | |
| Glomerular disease | Phase 1 | CN | 08 Oct 2022 | |
| Idiopathic Membranous Glomerulonephritis | Phase 1 | CN | 08 Oct 2022 | |
| Lupus Nephritis | Phase 1 | CN | 08 Oct 2022 | |
| Renal Insufficiency | Phase 1 | CN | 08 Oct 2022 | |
| Anemia, Hemolytic | Phase 1 | - | - | |
| Atypical Hemolytic Uremic Syndrome | IND Approval | CN | 10 Mar 2023 | |
| Cold Agglutinin Disease | IND Approval | CN | 10 Mar 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free